Craneware, the Edinburgh-based software provider for the US healthcare market, has announce its unaudited results for the six months ended 31 December 2018.
Revenue has
Profit before tax increased 7% to $9.3m compared to $8.7m for last year which allows a proposed interim dividend increased 10% to 11p (H1 2018: 10p per share).
Keith Neilson, CEO of Craneware plc commented, “We are delighted to report another strong set of results, delivering against our growth strategy. The strength of our trading performance to date and double-digit rate of growth
“As we enter the second half of the financial year we do so with excitement as we continue to build the business in line with the large market opportunity available to us. We believe that the breadth of our customer base and the quantity and quality of data within our solutions gives us the opportunity to sit at the heart of the move to value-based economics; collating and analysing the information that will support hospital-wide decision making and ultimately have a positive impact on the quality of healthcare.
“Our growing market opportunity, the strength of our sales pipeline and increasing long-term revenue visibility, mean we enter the second half of the financial year with great confidence for the future and the ongoing success of Craneware.”
